Adverse effects associated with peribulbar injection of triamcinolone for the treatment of thyroid eye disease: a retrospective case series

JOAQUIN MIGUEL GONZALEZ BARLATAY ; CARLA PAGANO BOZA; TOMAS ORTIZ BASSO; MERCEDES BENAVENTE; GUILLERMO VICENTE HERNÁNDEZ-GAUNA; EDUARDO JORGE PREMOLI

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA

CONSEL BRASIL OFTALMOLOGIA

Lugar: São Paulo; Año: 2022

0004-2749

Purpose: Peribulbar injection of triamcinolone is an alternative treatment for thyroid eye disease; however the safety profile of this therapeutic option remains controversial. The aim of this study was to describe the occurrence of local and systemic adverse effects after peribulbar injection of triamcinolone in patients with thyroid eye disease.Methods: This was a retrospective case series. Medical records of patients with thyroid eye disease treated with peribulbar injections of triamcinolone at a single academic institution between 2007 and 2019 were analyzed. Local and systemic complications were documented.Results: A total of 123 patients were treated. Only 11 patients (8.9%) developed local complications. The most frequent complication was the presence of superficial eyelid ecchymosis (nine patients; 7.3%). Notably, systemic complications (hyperglycemic and suprarenal inhibition after stop treatment) occurred in two patients (1.6%). All complications were transient, and the patients did not have any long-term sequelae.Conclusions: Peribulbar injection of triamcinolone for the treatment of thyroid eye disease is linked to a very low rate of local or systemic complications. Prospective studies are warranted to delve into this topic.